Together Pharma Ltd. Logo

Together Pharma Ltd.

Researches and produces medical cannabis products for domestic and European patients.

TGTR | TA

Overview

Corporate Details

ISIN(s):
IL0004620105
LEI:
Country:
Israel
Address:
85 Medinat Hayeudim St., 4672501 Herzliya
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Together Pharma Ltd. is a medical cannabis company engaged in the research, development, cultivation, production, and distribution of medicinal cannabis products. The company focuses on integrating clinical research with patient experience to develop precise cannabis strains tailored to specific therapeutic needs. It utilizes advanced agricultural technologies for irrigation, climate control, and ventilation to ensure high-quality cultivation compliant with stringent standards like GMP. Its product portfolio includes inflorescence, oils, and capsules, offered in various cannabinoid profiles such as THC-rich, CBD-rich, and balanced formulations. The company serves patients in its domestic market and is expanding into European markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-06-27 11:56
Regulatory Filings
Opening of Trading On Monday, June 28 2021-TOGETHER W 11
Hebrew (modern) 175.4 KB
2021-06-23 15:15
Regulatory Filings
Identifying Details of New Security: TGTR.W11
Hebrew (modern) 128.9 KB
2021-02-07 15:57
Regulatory Filings
TOGETHER W10– Opening of Trading on February 8,2021
Hebrew (modern) 209.8 KB
2021-02-03 12:42
Regulatory Filings
Identifying Details of New Security - TOGETHER W10
Hebrew (modern) 129.5 KB

Automate Your Workflow. Get a real-time feed of all Together Pharma Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Together Pharma Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Together Pharma Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cogent Biosciences, Inc. Logo
Developing precision small molecule therapies for cancers, autoimmune, and rare diseases.
United States of America
COGT
Coherus Oncology, Inc. Logo
Commercial-stage biopharma developing immuno-oncology therapies for hard-to-treat cancers.
United States of America
CHRS
COLLEGIUM PHARMACEUTICAL, INC Logo
Develops and commercializes abuse-deterrent medications for responsible chronic pain management.
United States of America
COLL
CollPlant Biotechnologies Ltd Logo
Develops rhCollagen for 3D bioprinting of tissues for regenerative & aesthetic medicine.
United States of America
CLGN
COMPASS Pathways plc Logo
Developing psilocybin therapies for severe mental health challenges like TRD and PTSD.
United States of America
CMPS
Compass Therapeutics, Inc. Logo
A clinical-stage oncology firm developing antibody therapies that engage the immune system.
United States of America
CMPX
Connect Biopharma Holdings Ltd Logo
Develops immune modulators for T cell-driven inflammatory diseases like asthma and COPD.
United States of America
CNTB
Context Therapeutics Inc. Logo
Clinical-stage biopharma developing T cell engaging bispecific antibodies for solid tumors.
United States of America
CNTX
Contineum Therapeutics, Inc. Logo
Develops oral small molecule therapies for neurological, inflammatory, and fibrotic diseases.
United States of America
CTNM
Corbus Pharmaceuticals Holdings, Inc. Logo
Clinical-stage oncology company developing targeted therapies like ADCs for cancer and obesity.
United States of America
CRBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.